1[1]Chandraratna RA. Rational design of receptor-selective retinoids[J]. J Am Acad Dermatol, 1998, 39(4 Pt 2): S124-128.
2[2]Duvic M, Asano AT, Hager C, et al. The pathogenesis of psoriasis and the mechanism of action of tazarotene[J]. J Am Acad Dermatol, 1998, 39(4 Pt 2): S129-133.
3[3]Nagpal S, Patel S, Asano AT, et al. Tazarotene-induced gene 1 (TIG1), a novel retinoic acid receptor-responsive gene in skin [J]. J Invest Dermatol, 1996, 106(2): 269-274.
4Trepicchio WL, Bozza M, Pedneault G, et al. Recombinant human IL- 11 attenuates the inflammatory response through down-regulation of proinflammatory cytokine release and nitric oxide production. J Immunol, 1996, 157:3627 - 3634.
5Oh CJ, Das KM, Gottlieb AB. Treatment with anti-tumor necrosis factor alpha (TNF-alpha) monoclonal antibody dramatically decreases the clinical activity of psoriasis lesions. J Am Acad Dermatol, 2000, 42:829 - 830.
6Ogilvie AL, Antoni C, Dechant C, et al. Treatment of psoriatic arthritis with antitumour necrosis factor-alpha antibody clears skin lesions of psoriasis resistant to treatment with methotrexate. Br J Dermatol, 2001, 144:587 -589.
7Ferenczi K, Burack L, Pope M, et al. CD69, HLA-DR and the IL-2R identify persistently activated T cells in psoriasis vulgaris lesional skin: blood and skin comparisons by flow cytometry. J Autoimmun,2000, 14:63 - 78.
8Zeltser R, Valle L, Tanck C, et al. Clinical, histological, and immunophenotypic characteristics of injection site reactions associated with etanercept: a recombinant tumor necrosis factor alpha receptor: Fc fusion protein. Arch Dermatol, 2001, 137:893 -8
9Krueger JG, Walters lB, Miyazawa M, et al. Successful in vivo blockade of CD25 ( high-affinity interleukin .2 receptor) on T cells by administration of humanized anti-Tac antibody to patients with psoriasis. J Am Acad Dermatol, 2000, 43:448-458.
10Reich K, Garbe C, Blaschke V, et al. Response of psoriasis to interleukin - 10 is associated with suppression of cutaneous type l inflammation, downregulation of the epidermal interleukin - 8/CXCR2 pathway and normalization of keratinocyte maturation. J I
